Email Newsletters

Pfizer Inc.

Aetna files lawsuit accusing drugmakers of price-fixing

Hartford-based Aetna Inc., a CVS Health company, had a post-holiday gift for several major drug manufacturers, filing...

Pfizer Inc. to acquire Global Blood Therapeutics for $5.4B

Drug giant Pfizer Inc. announced Monday that it has reached an agreement to pay $5.4 billion to...

YNHH officials: Omicron variant here; COVID numbers climbing

The number of patients hospitalized throughout the Yale New Haven Health system has risen sharply in recent...

Pfizer’s Groton site helped develop a COVID-19 vaccine. Now the question is, will it work?

Pfizer’s facility in Groton has a history of developing some of the most popular drugs ingested by Americans, including Zoloft, which treats anxiety, and Zithromax, able to kill the toughest bacteria.
- Advertisement -

Pfizer, Yale COVID-19 vaccine trial to get underway soon

Hundreds of area residents have signed up to participate in a study which will test the effectiveness of a potential vaccine against COVID-19.

Yale to assist with Pfizer COVID-19 vaccine human trial

New Haven area residents will have an opportunity to participate in a study of the effectiveness of a potential vaccine against COVID-19. 

🔒CT bioscience companies among global leaders in COVID-19 vaccine, treatment development

Connecticut bioscience companies are among the global leaders in COVID-19 vaccine and treatment development as the state faces one of the country's deadliest COVID-19 outbreaks.

4 more CT firms fined for DNC lapses

United Healthcare and three Connecticut companies have joined the list of those penalized for breaching the state's ethics code for failing to report their expenditures related to lobbyist breakfasts and dinners at Democrats' national convention two years ago.
- Advertisement -

Pfizer, Diageo fined $5K each for ethics violations

Spirits maker Diageo North America and pharmaceutical giant Pfizer Inc. have each agreed to pay a $5,000 fine because their lobbyists failed to disclose expenditures for receptions at the 2012 Democratic National Convention, the Office of State Ethics announced.

Startup’s cancer therapy preps for 2014 clinical trials

A Connecticut startup developing a new cancer treatment is drawing the eyes and interest of investors and big pharma, as it prepares to begin clinical trials this year on its drug discovery.
ADVERTISEMENT

Latest Stories

More Business News

Movers & Shakers

More Movers & Shakers | Submit an Announcement
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

Trust Officer

Torrington Savings Bank
,
Torrington, CT

Sales Professional

Hartford Business Journal
,
Hartford, CT
More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Hartford Business News

Stay up-to-date on the companies, people and issues that impact businesses in Hartford and beyond.

Close the CTA